A report on Malaria, Plasmodium vivax and Antimalarial medication
Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women.
- Antimalarial medicationThis parasite is the most frequent and widely distributed cause of recurring malaria.
- Plasmodium vivaxMost deaths are caused by P. falciparum, whereas P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.
- MalariaQuinine is an alkaloid that acts as a blood schizonticidal and weak gametocide against Plasmodium vivax and Plasmodium malariae.
- Antimalarial medicationThe recommended treatment for malaria is a combination of antimalarial medications that includes artemisinin.
- MalariaWhere an artemisinin-based combination therapy has been adopted as the first-line treatment for P. falciparum malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure.
- Plasmodium vivax5 related topics with Alpha
Chloroquine
3 linksChloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects.
]]Chloroquine has been used in the treatment and prevention of malaria from Plasmodium vivax, ''[[Plasmodium ovale|P.
In areas where resistance is present, other antimalarials, such as mefloquine or atovaquone, may be used instead.
Plasmodium falciparum
2 linksPlasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans.
In 1900, the Italian zoologist Giovanni Battista Grassi categorized Plasmodium species based on the timing of fever in the patient; malignant tertian malaria was caused by Laverania malariae (now P. falciparum), benign tertian malaria by Haemamoeba vivax (now P. vivax), and quartan malaria by Haemamoeba malariae (now P. malariae).
According to WHO guidelines 2010, artemisinin-based combination therapies (ACTs) are the recommended first-line antimalarial treatments for uncomplicated malaria caused by P. falciparum.
Plasmodium
2 linksGenus of unicellular eukaryotes that are obligate parasites of vertebrates and insects.
Genus of unicellular eukaryotes that are obligate parasites of vertebrates and insects.
The ensuing destruction of host red blood cells can result in malaria.
Over the course of the 20th century, many other species were discovered in various hosts and classified, including five species that regularly infect humans: P. vivax, P. falciparum, P. malariae, P. ovale, and P. knowlesi.
A number of drugs have been developed to treat Plasmodium infection; however, the parasites have evolved resistance to each drug developed.
Mefloquine
1 linksMefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria.
Mefloquine is used as a treatment for chloroquine-sensitive or resistant Plasmodium falciparum malaria, and is deemed a reasonable alternative for uncomplicated chloroquine-resistant Plasmodium vivax malaria.
It is not recommended for severe malaria infections, particularly infections from P. falciparum, which should be treated with intravenous antimalarials.
Sulfadoxine/pyrimethamine
0 linksSulfadoxine/pyrimethamine, sold under the brand name Fansidar, is a combination medication used to treat malaria.
For the treatment of malaria it is typically used along with other antimalarial medication such as artesunate.
The combination is considered to be more effective in treating malaria caused by Plasmodium falciparum than that caused by P. vivax, for which chloroquine is considered more effective, though in the absence of a species-specific diagnosis, the sulfadoxine-pyrimethamine combination may be indicated.